Showing results (41-50 of 82) with videos related to
Sort By:
Pageof 9
Frontiers in Endocrinology|September 26, 2022
Lipocalin-2 is associated with FGF23 in WNT1 and PLS3 osteoporosisPetra Loid, Helena Hauta-Alus, Outi Mäkitie, et al.Acta Paediatrica (Oslo, Norway : 1992)|September 15, 2023
Low bone mineral density and reduced bone-specific alkaline phosphatase in 5q spinal muscular atrophy type 2 and type 3: A 2-year prospective study of bone healthAnna-Karin Kroksmark, Lars Alberg, Mar Tulinius, et al.Platelets|July 12, 2011
Acidic preparations of lysed platelets upregulate proliferative pathways in osteoblast-like cells as demonstrated by genome-wide microarray analysisOla Wahlström, Cecilia Halling Linder, Anna Ansell, et al.Scientific Reports|December 23, 2020
Altered cortical bone strength and lean mass in young women with long-duration (19 years) type 1 diabetesDaniel Novak, Gun Forsander, Eva Kristiansen, et al.Bone|January 15, 2013
Isozyme profile and tissue-origin of alkaline phosphatases in mouse serumCecilia Halling Linder, Ulrika H Englund, Sonoko Narisawa, et al.Bone Reports|September 2, 2025
Lifetime follow-up of an adult patient with pediatric-onset hypophosphatasia complicated with advanced chronic kidney diseaseMaria Sääf, Sigridur Björnsdottir, Mathias Haarhaus, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 23, 2020
Biomarkers in WNT1 and PLS3 Osteoporosis: Altered Concentrations of DKK1 and FGF23Riikka E Mäkitie, Anders Kämpe, Alice Costantini, et al.JAMA Network Open|June 12, 2024
Limosilactobacillus reuteri 6475 and Prevention of Early Postmenopausal Bone Loss: A Randomized Clinical TrialGiulia Gregori, Aldina Pivodic, Per Magnusson, et al.Bone|June 6, 2025
Adolescents with long-duration type 1 diabetes have low bone mass and reduced levels of bone indices reflecting altered bone resorptionDiana Swolin-Eide, Auste Pundziute Lyckå, Daniel Novak, et al.JBMR Plus|March 31, 2025
Prevention of glucocorticoid-induced impairment of bone metabolism-a randomized, placebo-controlled, single centre proof-of-concept clinical trialGiulia Gregori, Lisa Johansson, Lena Silberberg, et al.Pageof 9